| __timestamp | Ionis Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 241751000 | 5758000 |
| Thursday, January 1, 2015 | 322292000 | 8423000 |
| Friday, January 1, 2016 | 344320000 | 11986000 |
| Sunday, January 1, 2017 | 374644000 | 15215000 |
| Monday, January 1, 2018 | 1820000 | 15356000 |
| Tuesday, January 1, 2019 | 4000000 | 16660000 |
| Wednesday, January 1, 2020 | 12000000 | 52459000 |
| Friday, January 1, 2021 | 11000000 | 75061000 |
| Saturday, January 1, 2022 | 14000000 | 87221000 |
| Sunday, January 1, 2023 | 9133000 | 83779000 |
| Monday, January 1, 2024 | 11215000 |
Cracking the code
In the competitive landscape of pharmaceuticals, cost efficiency is paramount. Ionis Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. have shown contrasting trends in their cost of revenue from 2014 to 2023. Ionis, with a peak cost of revenue in 2017, saw a significant reduction of over 97% by 2018, maintaining a lower cost trend thereafter. In contrast, Supernus exhibited a steady increase, with costs rising by over 1,400% from 2014 to 2022. This divergence highlights Ionis's strategic cost management, while Supernus's rising costs may reflect increased production or expansion efforts. Understanding these trends provides valuable insights into each company's operational strategies and market positioning. As the pharmaceutical industry continues to evolve, monitoring such financial metrics is crucial for investors and stakeholders aiming to gauge company performance and sustainability.
Comparing Cost of Revenue Efficiency: Eli Lilly and Company vs Ionis Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Supernus Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Incyte Corporation vs Ionis Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Ionis Pharmaceuticals, Inc.
Cost Insights: Breaking Down Pharming Group N.V. and Supernus Pharmaceuticals, Inc.'s Expenses
Corcept Therapeutics Incorporated vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Cytokinetics, Incorporated and Supernus Pharmaceuticals, Inc.
Cost Insights: Breaking Down Telix Pharmaceuticals Limited and Ionis Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Trends: Ionis Pharmaceuticals, Inc. vs CRISPR Therapeutics AG
Cost of Revenue Trends: Ionis Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Supernus Pharmaceuticals, Inc. vs Wave Life Sciences Ltd.
Comparing Cost of Revenue Efficiency: Supernus Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.